Dexmedetomidine prescribing in Australian intensive care units: an observational study
Open Access
- 30 May 2019
- journal article
- research article
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 49 (5), 477-481
- https://doi.org/10.1002/jppr.1529
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With SepsisJAMA, 2017
- A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubationJournal of Anaesthesiology Clinical Pharmacology, 2013
- Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patientsBritish Journal of Anaesthesia, 2012
- Dexmedetomidine: Current Role in Anesthesia and Intensive CareRevista Brasileira de Anestesiologia, 2012
- A high dose of dexmedetomidine using the BIS monitor™ for diagnostic and interventional cardiac catheterization in a toddler with congenital heart diseaseJournal of Anesthesia, 2011
- DexmedetomidineDrugs, 2011
- Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patientsCritical Care, 2011
- Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized TrialJAMA, 2009
- Dexmedetomidine: a review of clinical applicationsCurrent Opinion in Anaesthesiology, 2008
- ALPHA 2 ADRENOCEPTOR AGONISTS AND ANAESTHESIABritish Journal of Anaesthesia, 1993